racing medication and testing consortium

Drazin Calls On New Jersey Legislature To Enact Widespread Reforms, Including Track-Regulated Pharmacy

Dennis Drazin, the chairman and CEO of Darby Development, LLC, operator of Monmouth Park in New Jersey, released the following statement on Monday, March 16: In the wake of last Monday’s federal indictments in the horseracing industry, I wanted to take this opportunity to address the public, horsemen, media, employees and any other interested parties. […]

Continue reading
‘Protecting Racehorse Bone Health’: RMTC Approves Bisphosphonates Research Study

At its February 24 meeting at Gulfstream Park Racetrack in Hallandale Beach, Florida, the Racing Medication and Testing Consortium (RMTC) board approved the funding of a study on bisphosphonates through its Tactical Research Grant Program. The research will be conducted at Cornell University under the direction of Dr. Heidi Reesink. “This study is an important […]

Continue reading
Health And Safety Highlight Regulatory Veterinarian Continuing Education Conference

Sixty regulatory and official racetrack veterinarians from jurisdictions around the world participated in the third annual Regulatory Veterinarian Continuing Education Conference at Santa Anita Park on March 2 and 3. Presented by the Racing Medication and Testing Consortium (RMTC) and National Thoroughbred Racing Association (NTRA) Safety & Integrity Alliance, the meeting provided training and presented […]

Continue reading
Radosevich Returning From 15-Day Levamisole Suspension In Ohio

Jeffrey Radosevich, perennially the leading trainer at Mahoning Valley Race Course in Youngstown, Ohio, is set to return from a 15-day suspension for a medication violation in December. Radosevich was fined $500 and suspended by the board of stewards from Feb. 9 through Feb. 23 after Ron Paolucci Racing’s Dinesen, winner of the sixth race […]

Continue reading
Disqualified: Silver Dust Tested Positive For Levamisole After Louisiana Stakes

Silver Dust, winner of yesterday’s Grade 3 Mineshaft Stakes at the Fair Grounds, has been disqualified from his Jan. 18 win in the G3 Louisiana Stakes after testing positive for levamisole, reports the Daily Racing Form. Trainer Bret Calhoun agreed to a $1,000 fine and the disqualification, placing Silver Dust last. The Racing Medication and Testing […]

Continue reading
Joe Sharp Has Eight Horses Disqualified At Fair Grounds; Additional Cases Pending In Kentucky

Trainer Joe Sharp, who had eight horses disqualified at Fair Grounds in Louisiana because of positive tests for the Class 2 drug levamisole, said similar cases are pending from multiple horses from his barn who competed at the Churchill Downs fall meet in Kentucky. Daily Racing Form first reported that Sharp was fined $1,000 by […]

Continue reading
NYRA’s David O’Rourke: Horseracing Integrity Act ‘Vital To Equine Health, Integrity Of Our Sport’

The following letter from David T. O’Rourke, president and CEO of the New York Racing Association, was provided to Rep Jan Schakowsky, chair, and Rep. Cathy McMorris Rodgers, ranking member, of the U.S. House of Representatives’ Energy and Commerce Committee’s Subcommittee on Consumer Protection and Commerce. The subcommittee is conducting a hearing on the Horseracing […]

Continue reading
Chrome, Zenyatta, Tapit And More: RMTC To Auction Popular Horse Halters For Tactical Research Program

Beginning at 1 p.m. ET on December 2 and running for one week, the Racing Medication and Testing Consortium (RMTC), an industry 501(c)(3) nonprofit organization, will auction off halters of history-making racehorses, stallions and broodmares on its eBay page. All proceeds from this auction go to the RMTC’s Tactical Research Program, which funds studies focused on the […]

Continue reading
RMTC Approves New Restrictions On Non-Steroidal Anti-Inflammatories

During a November 15 meeting by phone, the Racing Medication and Testing Consortium (RMTC) board approved further regulations and stacking prohibitions, as well as corresponding threshold and penalty recommendations, for non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular (IA) injections.  The RMTC board has recommend a 48-hour Restricted Administration Time policy for all NSAIDs. Currently, the administration of one […]

Continue reading
Twitter Twitter
Paulick Report on Instagram